References
Margonis GA, Gani F, Buettner S, et al. Rates and patterns of recurrence after curative-intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium. HPB. 2016;18:872–8.
Kim BH, Kwon J, Chie EK, et al. Adjuvant chemoradiotherapy is associated with improved survival for patients with resected gallbladder carcinoma: a systematic review and meta-analysis. Ann Surg Oncol. 2018;25:255–64.
Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma. Retrieved at: http://www.ClinicalTrials.gov Identifier: NCT02798510. Accessed 18 Sept 2018.
Socha J, Michalak M, Wołąkiewicz G, et al. Nodal areas of potential geographic error in adjuvant radiotherapy for biliary tract cancer. Radiother Oncol. 2017;125:365–73.
Primrose JN, Fox R, Palmer DH, et al. Adjuvant capecitabine for biliary tract cancer: the BILCAP randomized study. J Clin Oncol. 2017;35(Suppl). Abstract 4006.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Disclosure
There are no conflicts of interest.
Additional information
ASO Author Reflections offer a brief invited commentary on the article, "Adjuvant Chemoradiotherapy Is Associated with Improved Survival for Patients with Resected Gallbladder Carcinoma: The Role of Radiation Therapy Revisited", Ann Surg Oncol. 2018;25:255–64.
Rights and permissions
About this article
Cite this article
Kim, B.H., Chie, E.K. & Kim, K. ASO Author Reflections: Survival Benefit of Adjuvant Chemoradiotherapy for Gallbladder Cancer: The Role of Radiation Therapy Revisited. Ann Surg Oncol 25 (Suppl 3), 788–789 (2018). https://doi.org/10.1245/s10434-018-6894-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-018-6894-7